Anti-Infectives | Lesson 1: Anti-Infectives
Page 1 of 22


  • Describe how cancer and cancer treatments effect the immune system
  • Identify which bacterial, fungal and viral infections cancer patients are most susceptible to
  • Use evidence based knowledge to rationalise which prophylactic anti-infective agents are most appropriate
  • Discuss the role of prophylaxis with antibiotics and Granulocyte Colony Stimulating Factor (GCSF) in preventing neutropenic sepsis
  • Lesson 1 is designed to provide a basic understanding of the appropriate use of prophylactic anti-infectives, all information in this lesson should be viewed in conjunction with your local guidelines. Due to the nature of infections there are likely to be geographical variations in treatments due to resistance patterns and local formularies
  • Where possible National Guidelines have been used as the primary reference source, links to these guidelines can be accessed via the “External links” box in the top right hand corner
  • By the end of Lesson 2, you will be able to demonstrate an understanding of the following points:
    • Antibacterial agents in the management of neutropenic sepsis and bacterial infections
    • Antiviral agents in the management of viral infections
    • Antifungal agents in the management of fungal infections
    • Central venous access device (CVAD) related infections and their management
    • The criteria for the use of action of GSCF for treatment